Respiratory Distress Syndrome in Premature Infant Clinical Trials

9 recruiting

Respiratory Distress Syndrome in Premature Infant Trials at a Glance

10 actively recruiting trials for respiratory distress syndrome in premature infant are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Toronto, Accra, and Bangui. Lead sponsors running respiratory distress syndrome in premature infant studies include Kafrelsheikh University, Karolinska Institutet, and Indiana University.

Browse respiratory distress syndrome in premature infant trials by phase

Treatments under study

About Respiratory Distress Syndrome in Premature Infant Clinical Trials

Looking for clinical trials for Respiratory Distress Syndrome in Premature Infant? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Respiratory Distress Syndrome in Premature Infant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Respiratory Distress Syndrome in Premature Infant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 4

Calfactant vs Poractant Alfa Using a Less Invasive Technique in Preterm Infants With Respiratory Distress Syndrome

SurfactantRespiratory Distress Syndrome in Premature InfantsRespiratory Distress Syndrome (RDS)
Uludag University234 enrolled5 locationsNCT07350018
Recruiting
Phase 4

Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa

Premature BirthRespiratory Distress Syndrome in Premature InfantSurfactant Deficiency Syndrome Neonatal+1 more
Indiana University1,512 enrolled8 locationsNCT06554522
Recruiting

Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting

Transient Tachypnea of the NewbornRespiratory Distress Syndrome in Premature InfantRespiratory Distress Syndrome, Newborn
Mayo Clinic500 enrolled1 locationNCT07344714
Recruiting
Not Applicable

30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants

Premature InfantRespiratory Distress Syndrome in Premature InfantNeurodevelopmental Outcome
University of Alberta1,200 enrolled21 locationsNCT03825835
Recruiting
Not Applicable

Surfactant Therapy Via Supraglottic Airway to Preterm Neonates With RDS in Vietnam

Respiratory Distress Syndrome in Premature Infant
Karolinska Institutet440 enrolled1 locationNCT07098910
Recruiting
Not Applicable

Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Preterm Neonates With Non-Invasive Respiratory Support

Mechanical Ventilation ComplicationRespiratory Distress Syndrome in Premature Infant
Kafrelsheikh University30 enrolled1 locationNCT06642285
Recruiting
Not Applicable

Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial

Respiratory Distress Syndrome in Premature InfantInfant, Newborn, DiseasesPrematurity+1 more
University College Dublin164 enrolled1 locationNCT06557551
Recruiting
Not Applicable

The NONA-LISA Trial

Respiratory Distress Syndrome in Premature Infant
Rigshospitalet, Denmark324 enrolled4 locationsNCT05609877
Recruiting
Not Applicable

Effect of Nasal CPAP Versus NIPPV On Diaphragm Electrical Activity (Edi) In VLBW Preterm Infants

Respiratory Distress Syndrome in Premature InfantPreterm BirthPremature Lungs
Sunnybrook Health Sciences Centre24 enrolled1 locationNCT06295484
Recruiting
Not Applicable

Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns

SepsisPremature BirthIntraventricular Hemorrhage of Prematurity+3 more
Queen Fabiola Children's University Hospital180 enrolled2 locationsNCT06280872